WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2024 SCHEDULE 13G/A Report for Ultragenyx Pharmaceutical Inc. Common Stock (RARE)

Filing Manager
WELLINGTON MANAGEMENT GROUP LLP
Reporting Manager
Wellington Management Group LLP
Security
Ultragenyx Pharmaceutical Inc. Common Stock
Symbol
RARE
Shares outstanding
91,020,111 shares
Disclosed Ownership
2,457,543 shares
Ownership
2.7%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2025, 10:25:37 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wellington Management Group LLP 2.7% 2,457,543 0 2,108,360 Taisia Lowe Regulatory Analyst
Wellington Group Holdings LLP 2.7% 2,457,543 0 2,108,360 Taisia Lowe Regulatory Analyst
Wellington Investment Advisors Holdings LLP 2.7% 2,457,543 0 2,108,360 Taisia Lowe Regulatory Analyst